DANIEL DEGUISTO: Open Payments
NPI 1659045839 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$40 in 2 payments from 1 company in 2025. Trend: 2023 $147 · 2024 $19 · 2025 $40
Food & beverage: $40
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 2 | $40 |
Products named: OPSUMIT, UPTRAVI.
Industry payments across PA — which companies pay providers there.
